Salmonella enterica serotype typhimurium (S. typhimurium) boasts a broad host range and can be transmitted between livestock and humans. While members of this serotype can acquire resistance to antimicrobials, the temporal dynamics of this acquisition is not well understood. Using new York State (NYS) and its dairy cattle farms as a model system, 87 S. Typhimurium strains isolated from 1999 to 2016 from either human clinical or bovine-associated sources in NYS were characterized using wholegenome sequencing. More than 91% of isolates were classified into one of four major lineages, two of which were largely susceptible to antimicrobials but showed sporadic antimicrobial resistance (AMR) gene acquisition, and two that were largely multidrug-resistant (MDR). All four lineages clustered by presence and absence of elements in the pan-genome. the two MDR lineages, one of which resembled S. Typhimurium DT104, were predicted to have emerged circa 1960 and 1972. The two largely susceptible lineages emerged earlier, but showcased sporadic AMR determinant acquisition largely after 1960, including acquisition of cephalosporin resistance-conferring genes after 1985. These results confine the majority of AMR acquisition events in NYS S. typhimurium to the twentieth century, largely within the era of antibiotic usage. Salmonella enterica subsp. enterica serotype Typhimurium (S. Typhimurium) consistently ranks as one of the serotypes most commonly isolated from human clinical cases in the United States; in 2016, it was reported as being responsible for 4,581 culture-confirmed human infections in the U.S. alone 1. Additionally, S. Typhimurium is capable of infecting a broad range of hosts: it is frequently isolated not only from humans, but from animals as well, including livestock, rodents, and birds 2-4. Within the serotype, numerous S. Typhimurium lineages have been identified, several of which are notable due to their propensity for resistance to antimicrobials 5. Many of these lineages have been assigned using phage typing, a practice by which S. Typhimurium can be differentiated based on its susceptibility to lysis by phages of varying specificity 6. Host range can vary within phage type, as some phage types (e.g. DT104, DT204, DT49) are commonly associated with epidemics among livestock and humans 2,6,7 , while others exhibit a narrower host range (e.g. DT2 and DT99, which are highly virulent in pigeons) 6-9. Additionally, a number of S. Typhimurium lineages are often associated with distinct antimicrobial resistance (AMR) profiles; for example, S. Typhimurium DT104 is often characterized by its resistance to ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline (ACSSuT), although AMR profiles within a lineage can vary 10-13. While whole-genome sequencing (WGS) is being increasingly employed to characterize S. Typhimurium from diverse sources at high resolution, the bulk of the effort has focused on characterizing distinct lineages that have been responsible for human epidemics (e.g. DT104) 12,14. Furt...